W. Bi < W. Birkmayer < W. Bitschnau

Facettes :

List of bibliographic references indexed by W. Birkmayer

Number of relevant bibliographic references: 15.

Ident.	Authors (with country if any)	Title
002821 (1989)	W. Birkmayer [Autriche] ; G. J. D. Birkmayer [Autriche]	Strategy and tactic of modern Parkinson therapy
002822 (1989)	G. J. D. Birkmayer [Autriche] ; W. Birkmayer [Autriche]	Stimulation of endogenous L‐dopa biosynthesis — a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)
002967 (1986)	W. Birkmayer [Autriche] ; D. Birkmayer [Autriche]	Iron, a new aid in the treatment of Parkinson patients
002A13 (1985)	W. Birkmayer [Autriche] ; J. Knoll [Hongrie] ; P. Riederer [Autriche] ; H. Youdim [Israël] ; Vera Hars [Hongrie] ; J. Marton [Hongrie]	Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
002B81 (1979)	W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; M. B. H. Youdim [Israël]	Distinction between benign and malignant type of parkinson's disease
002C33 (1977)	P. Riederer [Autriche] ; W. Birkmayer [Autriche] ; D. Seemann [Autriche] ; St. Wuketich [Autriche]	Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome
002C56 (1975)	W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; H. Youdim [Autriche] ; W. Linauer [Autriche]	The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil
002C69 (1974)	W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]	Nucleus ruber and L-Dopa psychosis: Biochemical post-mortem findings
002C82 (1973)	H. Bernheimer ; W. Birkmayer ; O. Hornykiewicz ; K. Jellinger ; F. Seitelberger	Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
002C83 (1973)	W. Birkmayer [Autriche] ; W. Danielcyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]	L-dopa level in plasma, primary condition for the kinetic effect
002C95 (1972)	W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche]	The balance of biogenic amines as condition for normal behaviour
002D01 (1972)	W. Birkmayer [Autriche] ; E. Neumayer [Autriche]	Die moderne medikamentöse Behandlung des Parkinsonismus
002D39 (1967)	W. Birkmayer [Autriche] ; M. Mentasti [Autriche]	Weitere experimentelle Untersuchungen über den Catecholaminstoffwechsel bei extrapyramidalen Erkrankungen (Parkinson- und Chorea-Syndrom)
002D45 (1966)	W. Birkmayer [Allemagne] ; O. Hornykiewicz [Allemagne]	Der L-Dioxyphenylalanin (=L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese und Behandlung der Parkinson-Akinese
002D51 (1964)	W. Birkmayer [Allemagne] ; O. Hornykiewicz [Allemagne]	Weitere experimentelle Untersuchungen über L-DOPA beim Parkinson-Syndrom und Reserpin-Parkinsonismus

---

List of associated KwdEn.i

Nombre de documents	Descripteur
2	NADH
1	DOPA biosynthesis
1	I‐dopa
1	Parkinson's disease
1	Parkinson's disease therapy
1	deprenyl
1	homovanillic acid
1	stimulation
1	therapy

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "W. Birkmayer" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "W. Birkmayer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    W. Birkmayer
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024